Cargando…
Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles
Rationale: The ability to treat invalidating neurological diseases is impeded by the presence of the blood-brain barrier (BBB), which inhibits the transport of most blood-borne substances into the brain parenchyma. Targeting the transferrin receptor (TfR) on the surface of brain capillaries has been...
Autores principales: | Johnsen, Kasper Bendix, Bak, Martin, Kempen, Paul Joseph, Melander, Fredrik, Burkhart, Annette, Thomsen, Maj Schneider, Nielsen, Morten Schallburg, Moos, Torben, Andresen, Thomas Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010987/ https://www.ncbi.nlm.nih.gov/pubmed/29930740 http://dx.doi.org/10.7150/thno.25228 |
Ejemplares similares
-
Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma
por: Johnsen, Kasper Bendix, et al.
Publicado: (2017) -
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
por: Thomsen, Maj Schneider, et al.
Publicado: (2022) -
Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology
por: Skjørringe, Tina, et al.
Publicado: (2015) -
Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration
por: Andersen, Hjalte Holm, et al.
Publicado: (2013) -
The blood-brain barrier studied in vitro across species
por: Thomsen, Maj Schneider, et al.
Publicado: (2021)